Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Rossi

Showing results (201-210 of 245) with videos related to

Pageof 25
Sort By:
Bioorganic & Medicinal Chemistry|January 5, 2010
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2)Daniela Rossi, Mariangela Urbano, Alice Pedrali, et al.
Autoimmunity Reviews|December 16, 2019
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoringSavino Sciascia, Irene Cecchi, Carlo Massara, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stabilityDaniela Rossi, Annamaria Marra, Pietro Picconi, et al.
Pharmacological Research|May 7, 2013
The C1 domain-targeted isophthalate derivative HMI-1b11 promotes neurite outgrowth and GAP-43 expression through PKCα activation in SH-SY5Y cellsVirpi Talman, Marialaura Amadio, Cecilia Osera, et al.
European Journal of Medicinal Chemistry|January 30, 2023
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agentsPasquale Linciano, Claudia Sorbi, Giacomo Rossino, et al.
Rheumatology (Oxford, England)|December 17, 2019
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patientsSavino Sciascia, Massimo Radin, Irene Cecchi, et al.
International Journal of Molecular Sciences|October 21, 2020
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R)Giacomo Rossino, Marta Rui, Luca Pozzetti, et al.
Chemmedchem|July 9, 2013
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds: promising neuroprotective agents acting as σ₁ receptor agonistsDaniela Rossi, Alice Pedrali, Raffaella Gaggeri, et al.
Molecules (Basel, Switzerland)|February 26, 2020
Insight into GEBR-32a: Chiral Resolution, Absolute Configuration and Enantiopreference in PDE4D InhibitionValeria Cavalloro, Katia Russo, Francesca Vasile, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR ApplicationSerena Della Volpe, Roberta Listro, Michela Parafioriti, et al.
Pageof 25

Showing results (201-210 of 245) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry|January 5, 2010
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2)Daniela Rossi, Mariangela Urbano, Alice Pedrali, et al.
Autoimmunity Reviews|December 16, 2019
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoringSavino Sciascia, Irene Cecchi, Carlo Massara, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stabilityDaniela Rossi, Annamaria Marra, Pietro Picconi, et al.
Pharmacological Research|May 7, 2013
The C1 domain-targeted isophthalate derivative HMI-1b11 promotes neurite outgrowth and GAP-43 expression through PKCα activation in SH-SY5Y cellsVirpi Talman, Marialaura Amadio, Cecilia Osera, et al.
European Journal of Medicinal Chemistry|January 30, 2023
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agentsPasquale Linciano, Claudia Sorbi, Giacomo Rossino, et al.
Rheumatology (Oxford, England)|December 17, 2019
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patientsSavino Sciascia, Massimo Radin, Irene Cecchi, et al.
International Journal of Molecular Sciences|October 21, 2020
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R)Giacomo Rossino, Marta Rui, Luca Pozzetti, et al.
Chemmedchem|July 9, 2013
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds: promising neuroprotective agents acting as σ₁ receptor agonistsDaniela Rossi, Alice Pedrali, Raffaella Gaggeri, et al.
Molecules (Basel, Switzerland)|February 26, 2020
Insight into GEBR-32a: Chiral Resolution, Absolute Configuration and Enantiopreference in PDE4D InhibitionValeria Cavalloro, Katia Russo, Francesca Vasile, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR ApplicationSerena Della Volpe, Roberta Listro, Michela Parafioriti, et al.
Pageof 25